FLR

Analyst Note: Fluor Corporation (FLR)

Date: 2026-06-13 Current Price: $53.66

1. Structural Readiness

• State: Context-only.
• Conservative Entry: Not yet defined (awaiting confirmed breakout).
• Aggressive/Pre-breakout Entry: Not defined (context-only state).
• Breakout Level: Not yet established (requires price action above the coil high).
• Current Price: $53.66.
• Extension: Not applicable (price is within the coil range, not extended above the breakout).
• ATR Context: Current ATR is 4.4% (High). This indicates elevated volatility, which is within the historical "sweet spot" (4–6%) for structural setups, suggesting sufficient momentum for a move but requiring careful position sizing.

2. Thesis Layer

• Primary Secular Thesis: Critical Minerals & Materials → Processing / Refining / Onshoring.
• *Directness:* High. Fluor is a direct beneficiary, evidenced by the "Urban Solutions" segment's focus on mining and metals, and specific project adjustments in metals projects (E14). The company's pipeline has grown 50% in the last 12 months, driven by demand in critical minerals and refining (E2, E5).
• Secondary Secular Themes:
• Energy Transition & Electrification: Fluor is positioned in grid modernization, nuclear power (SMR), and carbon capture (E25, E26, E28). The sale of NuScale shares (E9) and the TeraWulf data center agreement (E8) highlight exposure to power infrastructure and nuclear energy.
• AI Infrastructure: While listed as a tertiary theme with low confidence, the TeraWulf agreement for a 480MW data center campus (E8) provides a direct, albeit specific, link to AI power demand.
• Conviction Weighting: The combination of a 50% pipeline increase and specific "critical minerals" exposure creates a strong thematic overlay. The company is not just a passive observer but an active executor of onshoring and energy transition projects, with margins on new awards outperforming the backlog average (E3).

3. Business Overview

Fluor Corporation is a global enterprise delivering engineering, procurement, and construction (EPC), fabrication, and operational support across four primary divisions: Energy Solutions, Urban Solutions, Mission Solutions, and Other (E23, E24).

• Backlog & Revenue: As of March 31, 2026, total backlog stood at $25.731 billion, a slight increase from the $25.536 billion recorded at year-end 2025 (E4, E10, E11). Management notes that front-end work represents over $60 billion of potential revenue if clients proceed (E1).
• Segment Performance:
• Urban Solutions: Revenue grew to $2.437 billion (from $2.157 billion), driven by advanced technologies, life sciences, and mining/metals (E12).
• Energy Solutions: Revenue declined to $703 million (from $1.206 billion), reflecting a shift in project mix or timing (E12).
• Mission Solutions: Revenue was $523 million (from $597 million) (E12).
• Project Adjustments: The company recorded $1.1 billion in positive project adjustments during the quarter, including scope increases on a DOE project and cost growth on a metals project (E4, E14).
• Asset Sales: In February 2026, Fluor completed the sale of all 71 million shares of NuScale, generating $1.35 billion in proceeds (E9, E21).
• Guidance: Management narrowed full-year 2026 adjusted EBITDA guidance to $525 million to $560 million (E6).
• Risk Factors: Earnings before taxes decreased in 2026 due to an unfavorable court ruling on a DOD project and cost growth on a large mining joint venture, partially offset by the gain on the sale of CFHI (E15).
• Customer Concentration: 17% of 2025 revenue came from U.S. government agencies, and a single Urban Solutions customer accounted for 15% of revenue (E17, E18). 81% of the backlog is reimbursable (E16).

4. Archetype and Conviction

• Archetype: Quality Compounder (with cyclical recovery elements).
• *Fit:* The company demonstrates a "Quality Compounder" profile through its expanding pipeline (50% growth), improving margins on new awards (200 bps higher than backlog average), and successful execution of large-scale, complex projects (E2, E3). The "recovery" element is visible in the positive project adjustments and the strategic divestiture of non-core assets (NuScale) to fund growth or strengthen the balance sheet.
• Valuation Context: Forward consensus EPS for FY1 is $2.59 and FY2 is $3.28 (E37). At a current price of $53.66, the stock trades at approximately 20.7x FY1 EPS and 16.4x FY2 EPS.
• Conviction Stack:
• *Thesis Strength:* High. The alignment with critical minerals and energy transition is robust, supported by a 50% pipeline increase.
• *Evidence Quality:* High. Multiple primary sources (earnings transcripts, SEC filings) confirm backlog growth, margin expansion, and specific project wins.
• *Structural Quality:* Moderate to High. The backlog is substantial ($25.7B), but the high percentage of reimbursable contracts (81%) and government concentration (17%) introduce specific risk profiles.
• *Setup Readiness:* Forming. The setup is not yet confirmed. The price is holding above the support line, but the breakout has not fired. The 4.4% ATR suggests the volatility is sufficient for a move, but the direction is not yet confirmed by price action.
• *Rerating Potential:* Moderate. The market may re-rate the stock if the "Critical Minerals" thesis accelerates and the company successfully converts the $60B front-end work into backlog.

5. Invalidations, Strengths, and Gaps

• Invalidation Triggers:
• A significant deterioration in the backlog conversion rate (e.g., the $60B front-end work failing to materialize).
• Escalation of the unfavorable court ruling on the DOD project or further cost overruns on the mining joint venture (E15).
• Strengthening Factors:
• Confirmation of the "multibillion-dollar award" ($5B–$10B) mentioned in E7.
• Continued margin expansion on new awards (E3).
• Successful execution of the TeraWulf data center project (E8).
• Evidence Gaps:
• Specific Award Details: While a $5B–$10B award is mentioned (E7), the specific client and project name are not detailed in the provided evidence.
• Backlog Mix: The evidence does not explicitly break down the *quality* of the backlog (e.g., fixed-price vs. reimbursable) beyond the 81% reimbursable figure.
• Cash Flow: While proceeds from NuScale are noted, the specific impact on free cash flow and debt reduction is not detailed in the provided snippets.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: 50% increase in prospect pipeline over 12 months; margins on new awards 200 bps higher than current backlog; $1.35 billion proceeds from NuScale sale; $25.7 billion total backlog. Key risks: 81% of backlog is reimbursable (lower margin visibility); single customer concentration at 15% of revenue; unfavorable court ruling on DOD project impacting earnings; high volatility (4.4% ATR) in a forming setup. Expected path: Management expects the $60 billion front-end work to convert to backlog; if the $5B-$10B award is announced and executed, margins should expand further, supporting the EBITDA guidance. Expected horizon: 6 to 12 months for the thesis to play out as new awards convert to revenue.